MOMA Therapeutics

MOMA Therapeutics

Edit info

  • Founded: 2020
  • Location: Boston, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: Undisclosed
  • Funding: $150M B May 2022; $86M A Apr 2020
  • Investors: Third Rock Ventures


momatx.com

linkedin.com

job board


About:

MOMA Therapeutics is targeting the molecular machines that drive disease with precision medicine. Molecular machines present compelling therapeutic opportunities for disease treatment. They drive both cell growth and survival in cancer, and they are mutated in many genetic disorders. MOMA is singularly focusing on molecular machines and identifying opportunities to drug this class of proteins. To find drugs, MOMA is using their biomechanics engine that incorporates expertise in biochemistry, biophysics, structural biology, computation, chemistry and functional genomics. The platform exploits a key vulnerability to all enzymes in molecular machines: their dependence on well-coordinated conformational changes. MOMA will use this information to advance multiple oncology programs.

Jobs:

MOMA Therapeutics
Vice President, Regulatory Affairs
Cambridge, MA|1 day ago
Apply
MOMA Therapeutics
Director, CMC Lead
Cambridge, MA|100+ days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com